Home > Insider Trading > Filing (0001209191-13-029528)

Filing Details

Accession Number:: 0001209191-13-029528
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-05-30 14:47:01
Reporting Period:: 2013-05-28

Filing Date:: 2013-05-30
Accepted Time:: 2013-05-30 14:47:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1396814	Pacira Pharmaceuticals Inc.	PCRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1134657	Luke Evnin	C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-05-28	114,837	$30.62	1,061,535	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2013-05-28	74,980	$31.38	986,555	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2013-05-28	5,300	$32.14	981,255	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2013-05-29	20,411	$30.00	960,844	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	22,746	Direct

Footnotes

This transaction was pursuant to a 10b5-1 Plan.
The shares were sold as follows: 107,625 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 4,146 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 3,066 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. The Reporting Person is a member of BV LLC.
Represents the average sales price. The shares were sold between $30.00 and $31.00. The Reporting Person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 994,948 by BV IV QP, 38,334 by BV IV KG and 28,253 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 70,271 by BV IV QP, 2,707 by BV IV KG and 2,002 by AM BV4.
Represents the average sales price. The shares were sold between $31.01 and $32.01. The Reporting Person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 924,677 by BV IV QP, 35,627 by BV IV KG and 26,251 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 4,968 by BV IV QP, 191 by BV IV KG and 141 by AM BV4.
Represents the average sales price. The shares were sold between $32.12 and $32.33. The Reporting Person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The shares are held as follows: 919,709 by BV IV QP, 35,436 by BV IV KG and 26,110 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 19,129 by BV IV QP, 737 by BV IV KG and 545 by AM BV4.
The shares are held as follows: 900,580 by BV IV QP, 34,699 by BV IV KG and 25,565 by AM BV4. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.